Наши контакты:

Сервисы

OncoTriage

Информационно-аналитическая и образовательная система, помогающая врачам-гематологам лечить своих пациентов

OncoPub

Простой и быстрый способ поиска медицинских публикаций по лечению большинства видов онкологических заболеваний

OncoCalc

Калькулятор дозировок лекарственных препаратов для взрослых пациентов

М-БОТ

Помогаю найти информацию о лечении пациентов с множественной миеломой на основании открытых научных данных [веб-версия]


Новые публикации

Final results of a phase II study of CHOEP plus lenalidomide as initial therapy for patients with stage II-IV peripheral T-cell lymphoma.

Br J Haematol, 2023-05-22
PMID: 37217196
DOI: 10.1111/bjh.18885

Читать на PubMed
Efficacy and Safety of Bruton Tyrosine Kinase Inhibitor Plus Anti-CD20 Antibody Therapy Compared With Chemoimmunotherapy as Front-line Treatment for Chronic Lymphocytic Leukemia: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

J Immunother, 2023-05-23
PMID: 37216406
DOI: 10.1097/CJI.0000000000000471

Читать на PubMed
Real-world treatment patterns of novel drugs in relapsed or refractory acute lymphoblastic leukemia patients in Japan.

Future Oncol, 2023-05-22
PMID: 37212792
DOI: 10.2217/fon-2022-1314

Читать на PubMed
Plain language summary of the MAIA study of daratumumab plus lenalidomide and dexamethasone for the treatment of people with newly diagnosed multiple myeloma.

Future Oncol, 2023-05-22
PMID: 37212642
DOI: 10.2217/fon-2023-0082

Читать на PubMed
Glofitamab in relapsed/refractory diffuse large B-cell lymphoma: Real-world data.

Hematol Oncol, 2023-05-22
PMID: 37211991
DOI: 10.1002/hon.3174

Читать на PubMed
Outcomes of polatuzumab vedotin-containing regimens in real-world setting of relapsed and or refractory diffuse large B-cell lymphoma patients: a matched-control analysis from the Thai Lymphoma Study Group (TLSG).

Ann Hematol, 2023-05-18
PMID: 37202499
DOI: 10.1007/s00277-023-05273-8

Читать на PubMed
Magrolimab in Combination With Azacitidine in Patients With Higher-Risk Myelodysplastic Syndromes: Final Results of a Phase Ib Study.

J Clin Oncol, 2023-03-08
PMID: 36888930
DOI: 10.1200/JCO.22.01794

Читать на PubMed
Ibrutinib in combination with rituximab is highly effective in treatment of chronic lymphocytic leukemia patients with steroid refractory and relapsed autoimmune cytopenias.

Leukemia, 2023-05-18
PMID: 37202442
DOI: 10.1038/s41375-023-01891-3

Читать на PubMed
Clinical relevance of MYC/BCL2 expression and cell of origin in patients with diffuse large b-cell lymphoma treated with autologous transplant.

Bone Marrow Transplant, 2023-05-18
PMID: 37198234
DOI: 10.1038/s41409-023-02006-3

Читать на PubMed
Pelabresib (CPI-0610): An Exciting Novel Drug for the Treatment of Myelofibrosis.

Curr Hematol Malig Rep, 2023-05-17
PMID: 37195585
DOI: 10.1007/s11899-023-00696-6

Читать на PubMed
Survival outcomes following autologous stem cell transplant with melphalan 140mg/m2 versus 200mg/m2 preparative regimens in patients with multiple myeloma.

Leuk Lymphoma, 2023-05-18
PMID: 37199099
DOI: 10.1080/10428194.2023.2213366

Читать на PubMed
Rituximab/bendamustine/cytarabine for transplant-eligible patients with mantle cell lymphoma: A retrospective study.

Cancer Med, 2023-05-18
PMID: 37199050
DOI: 10.1002/cam4.6114

Читать на PubMed